XBiotech Inc (XBIT): Expected earnings per share growth for next year
XBiotech Inc. (XBIT) is facing price volatility and regulatory delays. The company develops fully human antibodies to combat cancer, minimizing the risk of rejection. Production is concentrated in its own laboratories, while logistics are outsourced. The projected net profit growth rate for n+1 reflects market expectations, with the value stabilizing at 0.00.
Metric breakdowns and analytics for XBiotech (XBIT)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization information:
- debt obligations and liquidity statistics:
- earnings and valuation multiples information:
XBIT - Final Profit|Future Profit XBiotech Inc.|XBIT - Company Value to Net Income|Forward P/E Multiple XBiotech Inc|XBIT - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization XBiotech|XBIT - Operating profit before amortization|Net earnings per share (EPS TTM) XBiotech|XBIT - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months xbiotech.com|XBIT - Expected net earnings per share growth this year|Expected earnings per share growth for next year XBiotech Inc.
Fundamental valuation:XBiotech Inc., XBIT
This indicator reflects the expert consensus forecast regarding net profit growth rates for the coming year. By analyzing the expected change in EPS for the next year, investors assess the trend of market expectations for capital management efficiency. For XBiotech Inc. (XBIT), this metric depends critically on the success of the antibody platform's clinical scaling and the prospects for licensing sales in oncology and dermatology.
Competitors of XBiotech Inc.
ONC (BeiGene Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Corp HALO|Expected earnings per share growth for next year RVMD (Revolution Medicines)|ascentage.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year CGON (CG Oncology)|UroGen Pharma Ltd - Net earnings per share growth forecast for next year|Bicara Bio - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Personalis Genomics PSNL|Erasca, Inc. (ERAS) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year delcath.com (DCTH)|Expected earnings per share growth for next year YMAB|AURA (Aura Biosciences Inc) - Projected earnings per share increase next year|Earnings growth forecast for next year CADL|ARAY - Expected net earnings per share growth next year|Earnings growth forecast for next year SLS (SELLAS Life Sciences Group)|ACTU - Expected earnings per share growth for next year|Citius Oncology - Earnings growth forecast for next year|Expected earnings per share trend next year HURA (TuHURA Biosciences, Inc.)|TARA (Protara) - Expected earnings per share growth for next year|Fate Pharma - Expected earnings per share trend next year|WHWK (Aadi Bioscience, Inc.) - Earnings growth forecast for next year|TScan (TCRX) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Champions Oncology (CSBR)|cel-sci.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year OSTX (OS Therapies Inc)|RADX - Expected earnings per share growth for next year|ARTV: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Adlai Nortye Ltd. ANL|VERU (Veru) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year TPST|XLO (Xilio Therapeutics Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year RENB|Earnings growth forecast for next year MURA|Consensus forecast of earnings per share growth for next year kairospharma.com|OnKure Therapeutics - Expected earnings per share growth for next year|Projected earnings per share increase next year GDTC (CytoMed Therapeutics Ltd)|Curis Corp - Earnings growth forecast for next year|Apollomics, Inc. (APLM) - Expected earnings per share growth for next year|THAR: Earnings growth forecast for next year|Advanced Biomed (ADVB) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Genprex|Projected earnings per share growth rate for next year CLDI (Calidi Bio)|Earnings growth forecast for next year SBFM|Expected earnings per share growth for next year xeneticbio.com XBIO|Earnings growth forecast for next year SLRX (Salarius Pharmaceuticals)|purple-biotech.com (PPBT) - Expected net earnings per share growth next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeiGene Ltd.)|CKPT (Checkpoint Therapeutics, Inc) - Expected earnings per share growth for next year|elevationoncology.com - Expected earnings per share trend next year|ICAD (iCAD Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year Ikena (IKNA)|Expected earnings per share growth for next year NTBL (Notable Labs)|Earnings growth forecast for next year viracta.com (VIRX)|Net earnings per share growth forecast for next year MorphoSys Corp MOR|Expected earnings per share trend next year NAYA|Ascentage Pharma Group - Earnings growth forecast for next year
